Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT02677896 |
| Title | A Study of Enzalutamide Plus Androgen Deprivation Therapy (ADT) Versus Placebo Plus ADT in Patients With Metastatic Hormone Sensitive Prostate Cancer (mHSPC) |
| Acronym | ARCHES |
| Recruitment | Completed |
| Gender | male |
| Phase | Phase III |
| Variant Requirements | No |
| Sponsors | Astellas Pharma Global Development, Inc. |
| Indications | |
| Therapies | |
| Age Groups: | adult |
| Covered Countries | USA | SWE | SVK | ROU | POL | NZL | NLD | ITA | ISR | GBR | FRA | FIN | ESP | DNK | DEU | CAN | BEL | AUS | ARG |